Company Filing History:
Years Active: 2012
Title: Innovations of Oriol Llera Soldevila
Introduction
Oriol Llera Soldevila is a notable inventor based in Girona, Spain. He has made significant contributions to the field of pharmacology, particularly in the development of compounds that interact with adrenergic receptors. His work is characterized by a focus on therapeutic applications that can improve patient outcomes.
Latest Patents
Oriol holds a patent for "Derivatives of 4-(2-amino-1-hydroxyethyl)phenol as agonists of the β2 adrenergic receptors." This patent describes various derivatives of 4-(2-amino-1-hydroxyethyl)phenol, which are utilized in pharmaceutical compositions. These compounds are recognized for their potential use in therapy as agonists of the β2 adrenergic receptor, highlighting their importance in medical treatments.
Career Highlights
Oriol Llera Soldevila is currently associated with Almirall, S.A., a prominent pharmaceutical company. His role at Almirall allows him to engage in innovative research and development, contributing to the advancement of therapeutic solutions. His expertise in pharmacology and drug development has positioned him as a valuable asset in the industry.
Collaborations
Oriol has collaborated with notable colleagues such as Victor Giulio Matassa and Carlos Puig Duran. These collaborations have fostered a productive environment for innovation and have led to advancements in their respective fields.
Conclusion
Oriol Llera Soldevila's contributions to pharmacology and his innovative patent demonstrate his commitment to improving healthcare through scientific research. His work continues to influence the development of new therapeutic agents.